The N terminus of the capsid protein (CA) undergoes a considerable conformational change when the human immunodeficiency virus (HIV) protease cleaves it free from the Pr55
rangement, the N-terminal proline of CA [HIV P(1) CA ] folds back into the core of the protein to form a buried salt bridge (a hydrogen bond between two oppositely charged groups [35] ) with the side chain of an aspartate in helix 3 [HIV D (51) CA ], forming a ␤-hairpin structure in the first 13 amino acids of CA (15, 20, 37) . As formation of the salt bridge and the ␤-hairpin requires the free amino group of P(1) CA that is generated upon Pr55
Gag cleavage, these features are absent in the immature form of CA (20, 50, 55) .
Strong sequence conservation of the HIV CA salt bridge amino acids suggests that the salt bridge and ␤-hairpin may be structurally conserved among the mature CA proteins of most retroviruses (55) . In fact, these two structural elements present in mature HIV CA are also present in the other complete, innate mature CA structures reported thus far, those of human T-cell leukemia virus type 1 (8, 31) and Rous sarcoma virus (6, 32) CA. The conservation of the salt bridge and ␤-hairpin suggests that these structural features are important for CA function. A single role has been proposed for the N-terminal ␤-hairpin in mature CA: interactions between the ␤-hairpins of CA monomers may facilitate dimerization and core assembly (15, 20, 23, 55) . Amino acid substitutions in HIV CA that disrupt the salt bridge, thereby destabilizing the ␤-hairpin, cause a variety of viral defects, including abnormal mature core morphology and loss of infectivity (13, 51, 55) . Because the conformational change in the CA N terminus is essential for proper CA function in the virus life cycle, the interactions that facilitate the formation of the ␤-hairpin and the salt bridge in mature CA are important potential targets for antiviral drug design (50; reviewed in reference 29) .
In this study, we identified a conserved threonine [T (47) CA ] required for replication of SIVmac239. The results of virolog-ical assays using a panel of polar and nonpolar substitutions of T (47) CA in SIV CA demonstrate that hydrogen bonding at this position is critical for the proper function of CA in viral infectivity and virion release. In addition, strong phenotypic similarities were observed between alanine substitution mutants of T(47) CA and a proximal aspartate, D(50) CA . Using the coordinates of the HIV CA N-terminal domain (15), we constructed a homology model of SIV CA. In this model, T(47) CA and D (50) CA are directly hydrogen bonded to each other. This observation, coupled with the phenotypic similarities between T(47) CA and D(50) CA mutants, strongly suggests that hydrogen bonding between T(47) CA and D (50) CA is essential for viral replication. As hydrogen bonding between these two residues is present in HIV CA as well, this interaction may provide a novel target for inhibitors of HIV replication.
MATERIALS AND METHODS
Mutagenesis and cloning. SIVmac239 gag mutants were generated by using the cloned 5Ј (p239SpSp5Ј) and 3Ј (p239SpE3Ј) halves of the SIVmac239 genome in the vectors pBSϩ and pBSϪ, respectively (AIDS Research and Reference Reagent Program) (30, 42) . In brief, p239SpSp5Ј was subjected to in vitro mutagenesis with the QuikChange mutagenesis kit (Stratagene, Cedar Creek, Tex.). Mutagenesis primers (Keystone Labs, Camarillo, Calif.) were designed according to the recommendations of the QuikChange manufacturer. The codon alterations resulting in amino acid substitutions in MA or CA were GGC3GCA for G(2)A MA , CCA3GCA for P(1)A CA , GAC3GCC for D(50)A CA , ACC3 GCC for T(47)A CA , ACC3TGC for T(47)C CA , ACC3TCC for T(47)S CA , and ACC3GTC for T(47)V CA . To generate full-length, mutant SIVmac239 in pBSϪ, mutant p239SpSp5Ј and wild-type p239SpE3Ј were both digested with SphI (Invitrogen Corporation, Carlsbad, Calif.) and ligated. All clones were verified by sequencing the complete coding region of the viral genome.
Cell culture and reagents. CEMϫ174 cells, a human T-cell/B-cell hybrid line (48) (a generous gift from James Hoxie [University of Pennsylvania]), were cultured as described previously (45) . African green monkey kidney COS-1 cells (American Type Culture Collection, Manassas, Va.) were cultured like human embryonic kidney 293T cells (American Type Culture Collection) as described previously (4), except with gentamicin (0.5 mg/ml) instead of penicillin-streptomycin.
Viral growth and infectivity. CEMϫ174 cells (5 ϫ 10 6 ) were transfected with 12 g of viral DNA by electroporation at 200 V and 960 F using a Gene Pulser (Bio-Rad, Hercules, Calif.). Reverse transcriptase (RT) activity in cell-free supernatants from transfected cultures was analyzed at various times posttransfection by using a standard RT assay (7) . The infectivity (LuSIV assay; see below) and 50% tissue culture infective dose (TCID 50 ) were determined for viral stocks generated by transfection of 293T (human embryonic kidney) cells and COS-1 (African green monkey kidney) cells in 10-cm dishes with 7.5 g of wild-type or mutant infectious viral DNA by using Lipofectamine and Plus reagents (Invitrogen), according to the manufacturer's recommendations. The 293T and COS-1 cell lines were chosen for this study because they are derived from species susceptible to HIV and SIV, respectively. For the LuSIV assay, 293T-and COS-1-derived virus stocks were normalized by RT activity and used to infect LuSIV cells as previously described (45) . Numbers represent the fold induction of luciferase activity over background at 2 days postinfection. The TCID 50 assay was performed as described previously (61) .
Metabolic labeling. 293T cells or COS-1 cells grown in 10-cm dishes were transfected as described above. The following day, cells were labeled with 55.5 Ci of Tran 35 S-label (ICN Pharmaceuticals, Inc., Costa Mesa, Calif.) per ml and incubated for 6 h at 37°C. Cells were lysed in modified radioimmunoprecipitation assay (RIPA) buffer as described previously (1) and sonicated. Cell supernatants were filtered through a Millex-HV 0.45-m syringe-driven filter (Millipore, Bedford, Mass.), pelleted, and lysed with modified RIPA buffer (similarly prepared lysates are referred to as virus lysates). Virus lysates were immunoprecipitated with either 6.5 g of immunoglobulin G (IgG)-purified SIV CA antiserum or 6.3 g of IgG-purified SIV antiserum. Cell lysates (500 g) were precleared and immunoprecipitated overnight at 4°C with 5 g of IgG-purified rabbit SIV CA antiserum. After immunoprecipitation, lysates were rotated at 4°C with protein A-Sepharose 4 Fast Flow (Amersham Pharmacia, Piscataway, N.J.) for 1 h. Pelleted Sepharose beads were washed with RIPA buffer, and proteins were resolved on 12.5% Tris-HCl Criterion precast gels (Bio-Rad) that were fixed and processed for autoradiography. Band densitometry was performed with Molecular Dynamics ImageQuant version 5.2 software (Amersham Pharmacia).
Transmission electron microscopy (EM). 293T cells were transfected with infectious viral DNA as described above. At 1 day posttransfection, the cells were pelleted and fixed at 4°C in 2.5% glutaraldehyde in Millonig's sodium phosphate buffer (pH 7.4) for 2 to 3 h and washed gently three times with Millonig's sodium phosphate buffer. Samples were then submitted to Electron Microscopy Bioservices (Monrovia, Md.) for analysis.
Virion morphology comparison. The proportion of mature wild-type, D(50)A CA , and T(47)A CA SIVmac239 virions with acentric cores was determined as follows. Mature virions in 50 photomicrographs of each virus sample were assessed for conical, centric, or acentric cores. Precautions were taken to minimize bias in this study: both the EM specialist and the individuals who analyzed the photomicrographs were blinded to the identity of each sample, and an outside individual randomly ordered and numbered the photomicrographs before analysis. To test the validity of the data, the reported proportions of acentric cores for each genotype were compared with the proportions obtained by an independent observer using a two-sided, two-sample test of proportions (46) . The proportion of acentric virions in T(47)A CA photomicrographs was compared to the proportions for wild-type and D(50)A CA individually by using a one-sided test for difference of proportions (46) .
Computer modeling. The structure of cyclophilin A in complex with the N terminus of HIV-1 CA (15) was used to create a homology model of the residues surrounding T(47) CA in SIVmac239 CA. To generate this model, a multiple amino acid alignment of the following Pr55
Gag sequences (obtained from the National Center for Biotechnology Information protein database) was generated with ClustalW (www2.ebi.ac.uk/clustalw) (52) and the BLOSUM matrix: SIVmac239 (accession no. AAA47632) (30), HIV-2 (accession no. FOLJG2) (24) , HIV-1 (accession no. AAK08483), equine infectious anemia virus (accession no. AAK21111), feline immunodeficiency virus (accession no. Q05313) (39), visna virus (accession no. NP_040839) (3), caprine arthritis encephalitis virus (accession no. P33458) (47) , and bovine immunodeficiency virus (accession no. NP_040562) (17) . Using this alignment as a guide, the Protein Modeler tool of the program QUANTA (Molecular Simulations) was used to replace amino acids in the local HIV-1 CA structure to match the sequence of SIVmac239 CA. The side chain of each mutated amino acid was rotated to find the best rotamer and further refined by energy minimization by using conjugate gradients. The depicted models of HIV-1 and SIV CA were rendered with SETOR (12) . Hydrogen bonding in HIV-1 CA or SIVmac239 CA was identified by using QUANTA and the coordinates published in reference 15 or our homology model, respectively. In this analysis, we used an upper limit for hydrogen bond length (the distance between donor and acceptor atoms, e.g., between N of donor residue and O of acceptor residue) of 3.3 Å .
RESULTS
Identification of a conserved threonine required for viral replication. In a previous study of the role of capsid phosphorylation in viral budding, we characterized a panel of CA substitution mutants in the infectious viral clone SIVmac239 (J. W. Roos, S. M. Rue, J. E. Clements, and S. A. Barber, submitted for publication). Phosphoamino acid analysis indicated that serine was the predominant phosphoamino acid, and a panel of mutants was created, replacing serines in consensus casein kinase II (CK2) and protein kinase C sites with alanine (Roos et al., submitted). Because threonine is also a potential site of phosphorylation by phosphoamino acid analysis (although to a lesser degree than serine [Roos et al., submitted] ), and to ensure that all known potential consensus sites were included in the mutagenesis study, we substituted alanine for each of the two threonines in consensus CK2 sites, in positions 47 [T(47)A CA ] and 208 [T(208)A CA ] of CA. Equivalent amounts of proviral DNA from each of these mutants and wildtype SIVmac239 were transfected into CEMϫ174 cells, and viruscontaining cell supernatants were subjected to an RT assay at various times posttransfection (Fig. 1A) . The T(47)A CA substitution severely compromised viral replication, while the T(208)A CA substitution only modestly delayed replication.
We next examined the infectivity of virions produced from 293T cells transfected with wild-type and mutant viral DNAs by the LuSIV assay (Fig. 1B) . The LuSIV assay, developed in our laboratory (45) , is based on a CEMϫ174 cell line stably transfected with a plasmid encoding luciferase under the control of the SIV long terminal repeat. Upon virus infection of this cell line, the viral Tat protein transactivates the long terminal repeat, inducing luciferase expression. Subsequent quantitation of luciferase activity provides a very sensitive measure of virus infectivity. While both substitution mutants were less infectious than wild-type virus in this assay, the infectivity of T(47)A CA virus was approximately fourfold lower than that of T(208)A CA virus.
To investigate whether either of the threonine substitutions affected virion morphology, we transfected 293T cells with wildtype or mutant infectious viral DNA and subjected them to transmission EM analysis. The T(208)A CA particles appeared to be morphologically wild type by EM (data not shown). In contrast, a predominance of the mature particles in photomicrographs of the T(47)A CA sample had acentric cores (core is collapsed and juxtaposed to the viral envelope [see below]).
Alignment of lentiviral Pr55
Gag protein sequences indicated that T(47) CA is well conserved among lentiviruses (Fig. 2) , underscoring the importance of this residue and suggesting that it may be similarly required for the replication of other members of this family of retroviruses. Interestingly, in all three virological analyses of the threonine substitution mutants, the T(47)A CA mutant bore a strong resemblance to previously characterized mutants with substitutions of the two residues that participate in the salt bridge in HIV CA, P(1)L CA and D(51)A CA . Like T(47)A CA SIV, P(1)L CA and D(51)A CA HIV do not replicate well, are noninfectious, and have largely acentric mature cores (13, 51, 55) . The similarities between these mutants, in conjunction with the fact that T(47) CA is highly conserved (suggesting its functional importance), prompted us to analyze this CA threonine residue in additional experiments.
Because the HIV P(1) CA and D(51) CA residues are both critical to the structure of the mature CA N terminus (15, 20, 37) , we hypothesized that SIV T(47) CA may have an important structural role as well. As the structure of SIV CA has not been reported, we investigated the crystal structure of HIV CA (15) to visualize the HIV homologue of SIV T (47) Since no previous study has investigated whether the sequence homologues of either of the HIV salt bridge partners are critical for SIV replication, for completeness, we substituted alanine for SIV P(1) CA in SIVmac239 [P(1)A CA ].
Finally, we changed the glycine at position 2 of the matrix domain to alanine in SIVmac239 [G(2)A MA ]. This substitution prevents myristoylation of Pr55
Gag and abolishes viral budding (5, 22, 38) , providing a negative control for viral replication. To ensure that no other mutations had spontaneously occurred in the cloning process, SIVmac239 mutants were verified by sequencing the entire coding region of the viral genome.
Growth kinetics of SIVmac239 substitution mutants. To compare the growth kinetics of our panel of viral mutants, CEMϫ174 cells were transfected with equivalent amounts of infectious wild-type or mutant viral DNA, and RT activity in virus-containing cell supernatants was measured at various times posttransfection (Fig. 3) . P(1)A CA virus consistently reached peak RT activity 6 days later than wild-type virus. In contrast, D(50)A CA virus replicated in only one of three independent transfections (Fig. 3) , and in this instance it was delayed by 18 days relative to the wild type and never replicated to wild-type levels.
All of the T(47) CA substitution mutants exhibited severely compromised viral replication: T(47)A CA , T(47)C CA , and T(47)S CA mutants consistently reached peak RT activity 8 to 12 days later than the wild type and never approached wild-type replication levels. The T(47)V CA mutant replicated in only one (data not shown) of three independent transfections, was delayed by 20 days relative to the wild type, and never reached wild-type levels. The observation that all of the T(47) CA substitution mutations inhibited viral replication indicates that a threonine at this position is crucial for the proper function of Gag in the viral life cycle.
Nonpolar substitutions of T(47) CA exhibited greatly reduced infectivity. We next investigated the relative infectivities of virions produced from cells transfected with wild-type SIV and each of our viral mutants using two assays, a standard TCID 50 assay (Fig. 4A and B ) and the LuSIV assay described above (Fig. 4C) . The results for each substitution mutant were consistent in both assays. In keeping with the phenotypes of mutants of the HIV salt bridge participant residues, HIV D(51)A CA and HIV P(1)L CA , D(50)A CA SIV was noninfectious and P(1)A CA SIV exhibited greatly reduced infectivity relative to wild-type virus (13, 51, 55) (Fig. 4) . All of the substitutions of T (47) Virion release and incorporation of viral proteins. Since the attenuation of viral replication observed for some of the substitution mutants was severe, the observed replication defects could have been manifested not only in virus entry into cells (described above) but also in virion release and/or viral protein incorporation. To assess whether any of the CA substitution mutants were defective in the release of nascent virions, 293T cells were transfected with equivalent amounts of wild-type or mutant SIVmac239 infectious viral DNA and metabolically labeled with [ 35 S]methionine-cysteine. Cell and virus lysates (see Materials and Methods) were immunoprecipitated with SIV CA antiserum and analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) followed by autoradiography (Fig. 5A) . As 293T cells are nonpermissive to SIV infection, this assay reflects one round of virus production. The band just above CA in this assay is the CA-p2 cleavage intermediate, similar to that described for Rous sarcoma virus (57) and HIV-1 (53). These gels were subjected to densitometric analysis, and the relative virion release efficiencies for the substitution mutants and wild-type SIV were compared by dividing the total amount of Gag in the virus lysate by the sum of the total amount of Gag in the cell and virus lysates (Fig. 5B) .
Consistent with previous studies (5, 22, 38) , no Gag was detected in G(2)A MA virus lysates, indicating a severe defect in virion release. The overaccumulation of Pr55
Gag observed in cells transfected with G(2)A MA SIV infectious viral DNA is consistent with the phenotype of HIV-1 G(2)A MA (22) . While P(1)A CA virus released approximately wild-type levels of Gag, the D(50)A CA mutant released only about 30% as much Gag into the cell supernatant as wild-type virus did, indicating a defect in particle production. Mutants with the nonpolar substitutions T(47)A CA and T(47)V CA released approximately 90 and 60% as much virus into the cell supernatant as wild-type virus, respectively, while mutants with the polar substitutions T(47)C CA and T(47)S CA released approximately wild-type levels of Gag. Similar results were obtained for the panel of mutants when cell and virus lysates from transfected 293T or COS-1 cells were analyzed directly by Western blot analysis with SIV CA antiserum or SIV antiserum (data not shown). Based on the infectivity data (Fig. 4) , the Gag that is released by the budding-deficient D(50)A CA , T(47)A CA and T(47)V CA mutants does not likely represent infectious virus.
The virion release defects observed for D(50)A CA , T(47)A CA , and T(47)V CA were somewhat unexpected, given that defective cell exit is not typical of substitutions in the CA N terminus (11, 43, 44, 56) . However, our group has recently characterized several other substitution mutants in this region of CA that also exhibit release defects (Roos et (Fig. 5C ). In keeping with the virion release data (Fig. 5A and B) , the G(2)A MA mutant exhibited a severe release defect. As envelope, RT, and integrase were detected for all of the other mutants, none of these substitutions caused a dramatic defect in viral protein incorporation.
Transmission EM phenotypes of wild-type and mutant SIVmac239. We investigated whether capsid morphology was affected by the CA substitutions by transmission EM of 293T cells transfected with the mutant panel. In the wild-type sample (Fig. 6A) , we observed budding, immature, and mature virus particles, consistent with normal lentiviral morphology. All three typical mature core phenotypes were present in this sample: centric (core is round and centered with respect to the viral envelope), conical (core is cone-shaped and centered), and acentric (described above). No intracellular or extracellular viral particles were observed in the G(2)A MA sample (data not shown), a finding that is in keeping with EM analysis of G (2) (13) alters the core morphology of mature virions, such that the mature cores are predominantly acentric. The core morphology of substitution mutants of the SIV sequence homologues of either of these HIV-1 salt bridge participants has not, to our knowledge, been examined. Unlike P(1)L CA HIV (13), P(1)A CA SIV was morphologically wild type by EM (Fig. 6B) . The differences between P(1)A CA SIV and P(1)L CA HIV are likely due to inherent differences in tolerance of substitutions at this position between HIV and SIV or to the fact that different substitutions were made. In contrast, consistent with the EM phenotype of D(51)A CA HIV, D(50)A CA SIV virions exhibited gross morphological abnormalities (Fig. 6C and D) . In this sample, several budding particles emerged from the same point in the plasma membrane, giving the buds an uncharacteristic multilobed shape (Fig. 6C) . Some of these buds had pinched off from the plasma membrane, forming oddly shaped, abnormally large immature particles. While relatively few mature virus particles were observed in cells transfected with the D(50)A CA mutant, all of them had acentric cores (see Fig. 6D for representative virions; see Table 1 and below).
Consistent with our earlier studies, the EM morphology of T(47)A CA virus (Fig. 6E, F , and G) was strikingly reminiscent of that of the D(50)A CA mutant. Budding virions had a branched or multilobed appearance, as though several virions were exiting the cell from the same region of the plasma membrane (Fig. 6E) . Importantly, there were some mature virions present in the T(47)A CA sample (Fig. 6F) , but those also appeared to have mostly acentric cores. Some extracellular immature virions in the T(47)A CA photomicrographs were tethered (Fig. 6G) , similar to the tethered structures observed in late domain and deletion mutants of HIV-1 p6 (10, 21, 59) . In order to quantitatively determine whether T(47)A CA produces a higher proportion of acentric mature virions than wildtype virus, we compared the proportions of mature wild-type, D(50)A CA , and T(47)A CA SIVmac239 virions with acentric, centric, and conical mature cores (Table 1) by statistical analysis (see Materials and Methods). T(47)A CA virus had an intermediate proportion of acentric mature cores, which was significantly different from both the wild-type and D(50)A CA proportions. Therefore, the T(47)A CA substitution causes acentric virion core morphology, but to a lesser degree than the D(50)A CA substitution.
T(47)C CA had approximately wild-type proportions of budding, immature, and mature virions, but roughly 40% of the mature cores appeared to have condensed in an aberrant manner, as they had either two electron-dense core regions or acentric cores (Fig. 6H) . Interestingly, the T(47)C CA mature core phenotype is similar to that reported for an HIV-1 p1-p6 cleavage site mutant (59) . Few (ϳ10%) mature virions were observed in the T(47)S CA sample, and the majority of these had abnormal or acentric cores (Fig. 6I) . Approximately 90% of the virions in this sample were budding or extracellular and immature, and many of these virions were connected as doublet or triplet particles (Fig. 6J) or tethered to the plasma membrane in chains (Fig. 6K) , a morphology that resembles both T(47)A CA and HIV-1 p6 mutants (10, 21, 59) . No extracellular mature virions were found in cells transfected with the T(47)V CA mutant. Approximately 95% of Gag in this sample accumulated at the plasma membrane in discrete patches (Fig. 6L) . Only 5% of the T(47)V CA virus particles were extracellular (data not shown), and the majority of these were large, multilobed, and immature, similar to the immature particles in the D(50)A CA sample.
Molecular modeling of SIVmac239 CA. As mentioned before, T(48) CA and D(51) CA form four hydrogen bonds in HIV CA (15) (see Fig. 7A for a model of these residues in HIV CA). Because both T(47)A CA and D(50)A CA had virion infectivity and release defects, and because the virion morphologies of these two mutants were so similar, we hypothesized that the interaction between HIV T(48) CA and HIV D(51) CA is conserved in SIV. To address this question, we constructed a model of SIVmac239 CA by homology to the crystal structure of the HIV-1 CA N terminus (15) using the program QUANTA (Fig. 7B ). Due to sequence constraints, we limited this model to the region surrounding T (47) a P values were obtained by using a one-sided test for differences in the proportion of acentric cores relative to T(47)A CA SIVmac239. NA, not applicable. drogen bonding at T(47) CA is essential to virus replication. First, mutants with nonpolar substitutions of T(47) CA were more compromised in virion infectivity and release than polar substitution mutants, indicating that hydrogen bonding at T(47) CA is specifically required for early and late events in the SIV life cycle. Secondly, T(47)V CA was severely deficient in virion release and infectivity relative to wild-type virus. As threonine and valine are quite similar from a space-filling perspective, the deficiencies of T(47)V CA are the result of the loss of hydrogen bonding at this position, rather than an alteration in the shape of the amino acid side chain.
The phenotypic similarities between the D(50)A CA mutant and T(47) CA substitution mutants [particularly the T(47)A CA mutant] indicate that these two residues likely have similar functionally important structural roles in SIV CA. Taken together, the results of the mutagenesis study and the modeling experiment presented herein strongly suggest that hydrogen bonding between SIV T(47) CA and D(50) CA is present in SIV CA and is required for viral replication. Because this interaction may be critical to CA function in the virus life cycle, these results provide a solid rationale for our ongoing efforts to determine the structure of mature SIV CA.
Two results indicate that T (47) (15, 50) , it is reasonable to conclude that the pattern of hydrogen bonding between T(48) CA and D(51) CA changes subsequent to the proteolytic release of the HIV CA N terminus. As such, the three additional hydrogen bonds present only in mature HIV CA may provide critical support to the salt bridge in its largely hydrophobic environment. We conclude that hydrogen bonding between the SIV homologues of HIV T(48) CA and D(51) CA is likely essential for proper CA function in virion release, infectivity, and core formation, suggesting that the interaction between these residues may be critical in HIV as well. If our conclusions about the requirement for hydrogen bonding between these two residues in SIV replication hold true in HIV, the change in hydrogen bonding between HIV T(48) CA and D(51) CA during the rearrangement of the CA N terminus may be a target for inhibitors of virus replication, since the structural constraints at these sites limit the acquisition of viable viral mutations.
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